New insights into the mechanisms of action of aspirin and its use in the prevention and treatment of arterial and venous thromboembolism

References

• SilversteinMDHeitJAMohrDNPettersonTMO’FallonWMMeltonLJ3rdTrends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based studyArch Intern Med199815865855939521222
   PubMed Web of Science ®Google Scholar
• GoldhaberSZPulmonary embolism thrombolysis: a clarion call for international collaborationJ Am Coll Cardiol19921922462471732348
   PubMed Web of Science ®Google Scholar
• PatronoCRoccaBAspirin, 110 years laterJ Thromb Haemost20097Suppl 125826119630812
   PubMedGoogle Scholar
• Gómez-OutesASuárez-GeaMLCalvo-RojasGDiscovery of anticoagulant drugs: a historical perspectiveCurr Drug Discov Technol2012928310421838662
   PubMedGoogle Scholar
• FerlundPStenfloJRoepstorffPThomsenJVitamin K and the biosynthesis of prothrombin. V. Gamma-carboxyglutamic acids, the vitamin K- dependent structures in prothrombinJ Biol Chem1975250156125613350323
   PubMed Web of Science ®Google Scholar
• HirshJDalenJEAndersonDROral anticoagulants: mechanism of action, clinical effectiveness, and optimal therapeutic rangeChest1998114445S469S9822057
   PubMed Web of Science ®Google Scholar
• KlauserWDütschMPractical management of new oral anticoagulants after total hip or total knee arthroplastyMusculoskelet Surg201397318919724249360
   PubMedGoogle Scholar
• ConnollySJEzekowitzMDYusufSRE-LY Steering Committee and InvestigatorsDabigatran versus warfarin in patients with atrial fibrillationN Engl J Med2009361121139115119717844
   PubMed Web of Science ®Google Scholar
• da SilvaRMNovel oral anticoagulants in non-valvular atrial fibrillationCardiovasc Hematol Agents Med Chem20141213825470147
   PubMedGoogle Scholar
• MekajYHMekajAYDuciSBMiftariEINew oral anticoagulants: their advantages and disadvantages compared with vitamin K antagonists in the prevention and treatment of patients with thromboembolic eventsTher Clin Risk Manag20151196797726150723
   PubMed Web of Science ®Google Scholar
• HirshJAnandSSHalperinJLFusterVMechanism of action and pharmacology of unfractionated heparinArterioscler Thromb Vasc Biol20012171094109611451734
   PubMed Web of Science ®Google Scholar
• WeitzJILow-molecular-weight heparinsN Engl J Med199733710668698
   Web of Science ®Google Scholar
• UndasABrummel-ZiedinsKMannKGWhy does aspirin decrease the risk of venous thromboembolism? On old and novel antithrombotic effects of acetyl salicylic acidJ Thromb Haemost2014121111761187
   Web of Science ®Google Scholar
• SneaderWThe discovery of aspirin: a reappraisalBMJ200032172761591159411124191
   PubMedGoogle Scholar
• PatronoCCollerBFitzGeraldFAHirshJRothGPlatelet-active drugs: the relationship among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic TherapyChest20041263 Suppl234S264S15383474
   PubMed Web of Science ®Google Scholar
• PedersenAKFitzGeraldGADose-related kinetics of aspirin. Presystemic acetylation of platelet cyclooxygenaseN Engl J Med198431119120612116436696
   PubMed Web of Science ®Google Scholar
• WilthauerJWohlgemutJUber aspirine (acetylsalicylic acid)Ther Mh (Halbmh)189913276 German
   Google Scholar
• EikelboomJWHirshJSpencerFABaglinTPWeitzJIAntiplatelet drugs: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest20121412 Supple89Se119S22315278
   PubMed Web of Science ®Google Scholar
• SatoHIshikawaKKitabatakeAJapan Atrial Fibrillation Stroke Trial GroupLow-dose aspirin for prevention of stroke in low-risk patients with atrial fibrillation: Japan Atrial Fibrillation Stroke TrialStroke20063744745116385088
   PubMed Web of Science ®Google Scholar
• No authors listedPrevention of pulmonary embolism and deep vein thrombosis with low dose aspirin: Pulmonary Embolism Prevention (PEP) trialLancet200035592121295130210776741
   PubMed Web of Science ®Google Scholar
• MiserWFAppropriate aspirin use for primary prevention of cardiovascular diseaseAm Fam Physician201183121380138621671538
   PubMed Web of Science ®Google Scholar
• TóthLMuszbekLKomáromiIMechanism of the irreversible inhibition of human cyclooxygenase-1 by aspirin as predicted by QM/MM calculationsJ Mol Graph Model2013409910923384979
   PubMed Web of Science ®Google Scholar
• LeiJZhouYXieDZhangYMechanistic insights into a classic wonder drug – aspirinJ Am Chem Soc20151371707325514511
   PubMed Web of Science ®Google Scholar
• MareeAOFitzgeraldDJVariable platelet response to aspirin and clopidogrel in atherothrombotic diseaseCirculation2007115162196220717452618
   PubMed Web of Science ®Google Scholar
• RinderCSStudentLABonanJLRinderHMSmithBRAspirin does not inhibit adenosine diphosphate-induced platelet alpha-granule releaseBlood19938225055127687162
   PubMed Web of Science ®Google Scholar
• PatrignaniPFilabozziPPatronoCSelective cumulative inhibition of platelet thromboxane production by low-dose aspirin in healthy subjectsJ Clin Invest1982696136613727045161
   PubMed Web of Science ®Google Scholar
• FuchsTABrillAWagnerDDNeutrophil extracellular trap (NET) impact on deep vein thrombosisArterioscler Thromb Vasc Biol20123281777178322652600
   PubMed Web of Science ®Google Scholar
• MeierTRMyersDDJrWrobleskiSKProphylactic P-selectin inhibition with PSI-421 promotes resolution of venous thrombosis without anticoagulationThromb Haemost200899234335118278184
   PubMed Web of Science ®Google Scholar
• ButenasSOrfeoTMannKGTissue factor in coagulation: Which? Where? When?Arterioscler Thromb Vasc Biol200929121989199619592470
   PubMed Web of Science ®Google Scholar
• SzczeklikAKrzanowskiMGóraPRadwanJAntiplatelet drugs and generation of thrombin in clotting bloodBlood1992808200620111391958
   PubMed Web of Science ®Google Scholar
• BrownAELitvinovRIDischerDEPurohitPKWeiselJWMultiscale mechanics of fibrin polymer: gel stretching with protein unfolding and loss of waterScience2009325594174174419661428
   PubMed Web of Science ®Google Scholar
• LordSTMolecular mechanisms affecting fibrin structure and stabilityArterioscler Thomb Vasc Biol2011313494499
   PubMed Web of Science ®Google Scholar
• LoewDVinazzerHDose-dependent influence of acetylsalicylic acid on platelet functions and plasmatic coagulation factorsHaemostasis1976542392491002006
   PubMedGoogle Scholar
• UndasASydorWJBrummelKMusialJMannKGSzczeklikAAspirin alters the cardioprotective effects of the factor XIII Val34Leu polymorphismCirculation20031071172012515735
   PubMed Web of Science ®Google Scholar
• WarkentinTEAspirin for dual prevention of venous and arterial thrombosisN Engl J Med2012367212039204123121404
   PubMed Web of Science ®Google Scholar
• YasueHOgawaHTanakaHEffects of aspirin and trapidil on cardiovascular events after acute myocardial infarction. Japanese Antiplatelets Myocardial Infarction Study (JAMIS) InvestigatorsAm J Cardiol19998391308131310235086
   PubMedGoogle Scholar
• IttamanSVVanWormerJJRezkallaSHThe role of aspirin in the prevention of cardiovascular diseaseClin Med Res2014123–414715424573704
   PubMedGoogle Scholar
• HoLLBrightonTWarfarin, antiplatelet drugs and their interactionsAust Prescr2002258185
   Google Scholar
• MorimotoTNakayamaMSaitoYOgawaHAspirin for primary prevention of atherosclerotic disease in JapanJ Atheroscler Thromb200714415916617726295
   PubMed Web of Science ®Google Scholar
• Antithrombotic Trialists’ (ATT) CollaborationBaigentCBlackwellLAspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trialsLancet200937396781849186019482214
   PubMed Web of Science ®Google Scholar
• BergerJSLalaAKrantzMJBakerGSHiattWRAspirin for the prevention of cardiovascular events in patients without clinical cardiovascular disease: a meta-analysis of randomized trialsAm Heart J20111621115124.e221742097
   PubMed Web of Science ®Google Scholar
• SeshasaiSRWijesuriyaSSivakumaranREffect of aspirin on vascular and nonvascular outcomes: meta-analysis of randomized controlled trialsArch Intern Med2012172320921622231610
   PubMed Web of Science ®Google Scholar
• WhitlockRPSunJCFremesSERubensFDTeohKHAmerican College of Chest PhysiciansAntithrombotic and thrombolytic therapy for valvular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest20121412 Supple576Se600S22315272
   PubMed Web of Science ®Google Scholar
• VandvikPOLincoffAMGoreJMAmerican College of Chest PhysiciansPrimary and secondary prevention of cardiovascular disease: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest20121412 Supple637Se668S22315274
   PubMed Web of Science ®Google Scholar
• YouJJSingerDEHowardPAAmerican College of Chest PhysiciansAntithrombotic therapy for atrial fibrillation: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest20121412 Supple531Se575S22315271
   PubMed Web of Science ®Google Scholar
• SmithSCJrBenjaminEJBonowROWorld Heart Federation and the Preventive Cardiovascular Nurses AssociationAHA/ACCF Secondary Prevention and Risk Reduction Therapy for patients with Coronary and other Atherosclerotic Vascular Disease: 2011 update: a guideline from the American Heart Association and American College of Cardiology FoundationCirculation2011124222458247322052934
   PubMed Web of Science ®Google Scholar
• LansbergMGO’DonnellMJKhatriPAmerican College of Chest PhysiciansAntithrombotic and thrombolytic therapy for ischemic stroke: Antithrombotic Therapy And Prevention Of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice GuidelinesChest20121412 Supple601Se636S22315273
   PubMed Web of Science ®Google Scholar
• HarrisWHSalzmanEWAthanasoulisCAWaltmanACDeSanctisRWAspirin prophylaxis of venous thromboembolism after total hip replacementN Engl J Med19772972312461249335247
   PubMed Web of Science ®Google Scholar
• AndersonFAJrHirshJWhiteKFitzgeraldRHJrHip and Knee Registry InvestigatorsTemporal trends in prevention of venous thromboembolism following primary total hip or knee arthroplasty 1996–2001: findings from the Hip and Knee RegistryChest20031246 Suppl349S356S14668417
   PubMed Web of Science ®Google Scholar
• HovensMMSnoepJDTamsmaJTHuismanMWAspirin in the prevention and treatment of venous thromboembolismJ Thromb Haemost2006471470147516839339
   PubMed Web of Science ®Google Scholar
• BecattiniCAgnelliGSchenoneAWARFASA InvestigatorsAspirin for preventing the recurrence of venous thromboembolismN Eng J Med20123662119591967
   PubMed Web of Science ®Google Scholar
• BrightonTAEikelboomJWMannKASPIRE InvestigatorsLow-dose aspirin for preventing recurrent venous thromboembolismN Engl J Med2012367211979198723121403
   PubMed Web of Science ®Google Scholar
• ČulićVAspirin for preventing venous thromboembolismN Engl J Med2013368877223425173
   PubMedGoogle Scholar
• ParaskevasKIAspirin for preventing venous thromboembolismN Engl J Med2013368877277323425174
   PubMedGoogle Scholar
• BeckerDMSegalJVaidyaDSex differences in platelet reactivity and response to low-dose aspirin therapyJAMA2006295121420142716551714
   PubMed Web of Science ®Google Scholar
• KhemasuwanDChaeYKGuptaSDose-related effect of statins in venous thrombosis risk reductionAm J Med2011124985285921783169
   PubMed Web of Science ®Google Scholar
• SimesJBecattiniCAgnelliGINSPIRE Study Investigators (International Collaboration of Aspirin Trials for Recurrent Venous Thromboembolism)Aspirin for the prevention of recurrent venous thromboembolism: the INSPIRE collaborationCirculation2014130131062107125156992
   PubMed Web of Science ®Google Scholar
• SobierajDMColemanCIPasupuletiVDeshpandeAKawRHernandezAVComparative efficacy and safety of anticoagulants and aspirin for extended treatment of venous thromboembolism: a network meta-analysisThromb Res2015135588889625795564
   PubMed Web of Science ®Google Scholar
• AndersonDRDunbarMJBohmERAspirin versus low-molecular-weight heparin for extended venous thromboembolism prophylaxis after total hip arthroplasty: a randomized trialAnn Intern Med20131581180080623732713
   PubMed Web of Science ®Google Scholar
• PrandoniPNoventaFMilanMAspirin and recurrent venous thromboembolismPhlebology201328Suppl 19910423482543
   PubMedGoogle Scholar
• WeitzJIBauersachsRBeyer-WestendorfJEINSTEIN CHOICE InvestigatorsTwo doses of rivaroxaban versus aspirin for the prevention of recurrent venous thromboembolisms. Rationale for and design of the EINSTEIN CHOICE studyThromb Haemost2015114364565025994838
   PubMed Web of Science ®Google Scholar
• BozicKJVailTPPekowPSMaselliJHLindenauerPKAuerbachADDoes aspirin have a role in venous thromboembolism prophylaxis in total knee arthroplasty patients?J Arthroplasty20102571053106019679434
   PubMed Web of Science ®Google Scholar
• JiangYDuHLiuJZhouYAspirin combined with mechanical measures to prevent venous thromboembolism after total knee arthroplasty: a randomized controlled trialChin Med J (Engl)2014127122201220524931228
   PubMed Web of Science ®Google Scholar
• StewartDWFreshourJEAspirin for the prophylaxis of venous thromboembolic events in orthopedic surgery patients: a comparison of the AAOS and ACCP guidelines with review of the evidenceAnn Pharmacother2013471637423324504
   PubMed Web of Science ®Google Scholar
• KnesekDPetersonTMarkelDCThromboembolic prophylaxis in total joint arthroplastyThrombosis20122012837896
   Google Scholar
• JamesonSSBakerPNDeehanDJPortAReedMREvidence-base for aspirin as venous thromboembolic prophylaxis following joint replacementBone Joint Res20143514614924837005
   PubMed Web of Science ®Google Scholar
• ThoratMACuzickJProphylactic use of aspirin: systematic review of harms and approaches to mitigation in the general populationEur J Epidemiol201530151825421783
   PubMed Web of Science ®Google Scholar
• FausaOSalicylate-induced hypoprothrombinemia. A report of four casesActa Med Scand197018854034085490567
   PubMedGoogle Scholar
• GargSKSarkerCRAspirin-induced thrombocytopenia on an immune basisAm J Med Sci197426721291324856606
   PubMed Web of Science ®Google Scholar
• WijnjaLSnijderJANiewegHOAcetylsalicylic acid as a cause of pancytopenia from bone-marrow damageLancet1996274677687704162323
   PubMedGoogle Scholar